SEK 1.6 million for development of synthetic bone
The Göteborg-based biomaterial company Promimic has been selected to receive a grant from Vinnova´s (Swedish Governmental Agency for Innovation Systems) national Research & Grow program.
Promimic has developed and patented a unique technique for producing the body´s own building block for bones and teeth, hydroxylapatite. This technique enables the production of nano-sized hydroxylapatite particles of the same structure and form that occur naturally in the body. The purpose of the project that has received a grant from Vinnova is to develop a new biomaterial that acts as synthetic bone and can replace bone tissue that has been lost after illness or trauma in a way that is natural for the body.
The company was founded in 2004 by two researchers from Chalmers University of Technology, Martin Andersson and Per Kjellin, along with Chalmers Innovation. Its customers can be found on the markets for implants and biosensors. The technique has been verified in independent collaboration with professor Ann Wennerberg at the School of Dentistry at Malmö University and with researchers at the University of Gothenburg.
There were a total of 407 applicants, 21 of which received grants for conducting R&D projects.
